Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for programmed sedation and analgesia after neurosurgery
ChiCTR2300078788Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Neurosurgical critical illness (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Wake up time and Extubation time. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Neurosurgical critical illness
Beyond the preview
Go deeper on ChiCTR2300078788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078788.